Peter Masci
About
In The Last Decade
Peter Masci
4 papers receiving 357 citations
Hit Papers
Peers
Comparison fields: 5 of 39
- Surgery 305
- Oncology 232
- Pulmonary and Respiratory Medicine 162
- Molecular Biology 53
- Pathology and Forensic Medicine 41
Countries citing papers authored by Peter Masci
This map shows the geographic impact of Peter Masci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Masci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Masci more than expected).
Fields of papers citing papers by Peter Masci
This network shows the impact of papers produced by Peter Masci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Masci. The network helps show where Peter Masci may publish in the future.
Co-authorship network of co-authors of Peter Masci
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Masci. A scholar is included among the top collaborators of Peter Masci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Masci. Peter Masci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers breakdown → | 321 |
| 3 | 2 | |
| 4 | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.